Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study

The aim of this study is to define the role of preoperative positron emission tomography/computed tomography (PET/CT) scan and sentinel lymph node (SLN) biopsy for nodal metastasis detection in Endometrial Cancer (EC) patients. From January 2014 to August 2016 patients affected by EC scheduled for s...

Full description

Bibliographic Details
Main Authors: Innocenza Palaia, Violante Di Donato, Angela Musella, Anna Di Pinto, Giusi Santangelo, Giuliano Petriglia, Pierluigi Benedetti Panici
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Journal of Investigative Surgery
Subjects:
Online Access:http://dx.doi.org/10.1080/08941939.2019.1675822
_version_ 1827817351362379776
author Innocenza Palaia
Violante Di Donato
Angela Musella
Anna Di Pinto
Giusi Santangelo
Giuliano Petriglia
Pierluigi Benedetti Panici
author_facet Innocenza Palaia
Violante Di Donato
Angela Musella
Anna Di Pinto
Giusi Santangelo
Giuliano Petriglia
Pierluigi Benedetti Panici
author_sort Innocenza Palaia
collection DOAJ
description The aim of this study is to define the role of preoperative positron emission tomography/computed tomography (PET/CT) scan and sentinel lymph node (SLN) biopsy for nodal metastasis detection in Endometrial Cancer (EC) patients. From January 2014 to August 2016 patients affected by EC scheduled for surgery underwent PET/CT scan and SLN mapping with indocyanine-green. Patients with suspicious lymph nodes at FDG-PET/CT underwent selective pelvic lymphadenectomy. In case of undetectable SLN, no further lymphadenectomy was performed if PET/CT scan was negative. Basic descriptive statistics were used to describe outcomes. A total of 83 patients were enrolled in the study. PET/CT scan was suggestive of nodal involvement in 15 patients. SLN were detected bilaterally in 78% of patients. Detection rate was influenced by patients’ BMI and surgical learning curve. Five patients were node-positive: all of these had hypermetabolic nodes on PET/CT scan; in one patient SLN was not detected. Ten out of 15 patients with suspicious nodes on PET/CT scan were node-negative. After a median follow up of 24 months all patients are alive. Four patients experienced recurrent disease. No nodal relapse was recorded. Lymphatic mapping with sentinel node biopsy is able to reduce morbidity associated with pelvic lymphadenectomy. Sentinel node assessment is a feasible and appealing procedure and should be performed in a specialized center. Detection rate strongly improves with learning curve, while is reduced in morbidly obese patients. PET/CT scan shows high sensitivity but moderate specificity for nodal metastasis and may help to avoid nodal dissection in patients with sentinel node mapping failure.
first_indexed 2024-03-12T00:33:03Z
format Article
id doaj.art-62b4d93756894b6bbea48271609571a3
institution Directory Open Access Journal
issn 0894-1939
1521-0553
language English
last_indexed 2024-03-12T00:33:03Z
publishDate 2021-07-01
publisher Taylor & Francis Group
record_format Article
series Journal of Investigative Surgery
spelling doaj.art-62b4d93756894b6bbea48271609571a32023-09-15T10:07:31ZengTaylor & Francis GroupJournal of Investigative Surgery0894-19391521-05532021-07-0134667267610.1080/08941939.2019.16758221675822Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective StudyInnocenza Palaia0Violante Di Donato1Angela Musella2Anna Di Pinto3Giusi Santangelo4Giuliano Petriglia5Pierluigi Benedetti Panici6Department of Obstetrics and Gynecology, Sapienza University of RomeDepartment of Obstetrics and Gynecology, Sapienza University of RomeDepartment of Obstetrics and Gynecology, Sapienza University of RomeDepartment of Obstetrics and Gynecology, Sapienza University of RomeDepartment of Obstetrics and Gynecology, Sapienza University of RomeDepartment of Obstetrics and Gynecology, Sapienza University of RomeDepartment of Obstetrics and Gynecology, Sapienza University of RomeThe aim of this study is to define the role of preoperative positron emission tomography/computed tomography (PET/CT) scan and sentinel lymph node (SLN) biopsy for nodal metastasis detection in Endometrial Cancer (EC) patients. From January 2014 to August 2016 patients affected by EC scheduled for surgery underwent PET/CT scan and SLN mapping with indocyanine-green. Patients with suspicious lymph nodes at FDG-PET/CT underwent selective pelvic lymphadenectomy. In case of undetectable SLN, no further lymphadenectomy was performed if PET/CT scan was negative. Basic descriptive statistics were used to describe outcomes. A total of 83 patients were enrolled in the study. PET/CT scan was suggestive of nodal involvement in 15 patients. SLN were detected bilaterally in 78% of patients. Detection rate was influenced by patients’ BMI and surgical learning curve. Five patients were node-positive: all of these had hypermetabolic nodes on PET/CT scan; in one patient SLN was not detected. Ten out of 15 patients with suspicious nodes on PET/CT scan were node-negative. After a median follow up of 24 months all patients are alive. Four patients experienced recurrent disease. No nodal relapse was recorded. Lymphatic mapping with sentinel node biopsy is able to reduce morbidity associated with pelvic lymphadenectomy. Sentinel node assessment is a feasible and appealing procedure and should be performed in a specialized center. Detection rate strongly improves with learning curve, while is reduced in morbidly obese patients. PET/CT scan shows high sensitivity but moderate specificity for nodal metastasis and may help to avoid nodal dissection in patients with sentinel node mapping failure.http://dx.doi.org/10.1080/08941939.2019.1675822abdominal surgerycancerendoscopyphysiologysurgical techniquemedical devices
spellingShingle Innocenza Palaia
Violante Di Donato
Angela Musella
Anna Di Pinto
Giusi Santangelo
Giuliano Petriglia
Pierluigi Benedetti Panici
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study
Journal of Investigative Surgery
abdominal surgery
cancer
endoscopy
physiology
surgical technique
medical devices
title Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study
title_full Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study
title_fullStr Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study
title_full_unstemmed Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study
title_short Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study
title_sort value of fluorodeoxyglucose positron emission tomography computed tomography and sentinel lymph node biopsy in endometrial cancer patients a prospective study
topic abdominal surgery
cancer
endoscopy
physiology
surgical technique
medical devices
url http://dx.doi.org/10.1080/08941939.2019.1675822
work_keys_str_mv AT innocenzapalaia valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy
AT violantedidonato valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy
AT angelamusella valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy
AT annadipinto valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy
AT giusisantangelo valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy
AT giulianopetriglia valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy
AT pierluigibenedettipanici valueoffluorodeoxyglucosepositronemissiontomographycomputedtomographyandsentinellymphnodebiopsyinendometrialcancerpatientsaprospectivestudy